Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Diabetes Mellitus · Hemophilia A

Takeda

Takeda clinical programs — 1179 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
Cambridge, USA HQ
1993 Founded
1,617 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Cambridge, USA
Founded
1993
Employees
1,617
Programs
1179
Drugs
359
Patents
1436
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Programs

Takeda projects

1,179 ClinicalTrials.gov programs sponsored by Takeda.

Takeda has 1,179 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

1,179 programs

Clinical programs

Page 24 of 25

  1. Ramelteon

    Takeda

    Schizophrenia

    approved small molecule completed

    1 trial

  2. Ramelteon

    Takeda

    Bipolar Disorder

    approved small molecule terminated

    2 trials

  3. Ramelteon

    Takeda

    Chronic Insomnia

    approved small molecule completed

    7 trials

  4. Ramelteon

    Takeda

    Circadian Dysregulation

    approved small molecule completed

    1 trial

  5. Ramelteon

    Takeda

    Insomnia

    approved small molecule completed

    6 trials

  6. Ramelteon

    Takeda

    Seasonal Affective Disorder

    approved small molecule completed

    1 trial

  7. Ramelteon

    Takeda

    ADHD With Sleep Onset Insomnia

    approved small molecule completed

    1 trial

  8. Ramelteon (RozeremR)

    Takeda

    Insomnia

    approved small molecule terminated

    1 trial

  9. Ramelteon and Placebo

    Takeda

    Chronic Obstructive Pulmonary Disease

    approved small molecule completed

    2 trials

  10. Ramelteon and zolpidem

    Takeda

    Chronic Insomnia

    approved small molecule completed

    1 trial

  11. Ramelteon, zolpidem and placebo

    Takeda

    Insomnia

    approved small molecule completed

    1 trial

  12. Recombinant Protein-Free Factor VIII (rAHF-PFM)

    Takeda

    Hemophilia A

    approved small molecule completed

    1 trial

  13. SPD489

    Takeda

    ADHD Specifically With Executive Function Impairment

    approved small molecule completed

    1 trial

  14. SPD489 (Lisdexamfetamine dimesylate)

    Takeda

    Attention-Deficit/Hyperactivity Disorder

    approved small molecule completed

    1 trial

  15. TACHOSIL GROUP

    Takeda

    Lymphocele

    approved mab completed

    1 trial

  16. TAK-085

    Takeda

    Hyperlipidemia

    approved small molecule completed

    2 trials

  17. Tinoridine HCl

    Takeda

    Pain

    approved small molecule completed

    1 trial

  18. Treatment Algorithm A

    Takeda

    Colitis, Ulcerative

    approved mab active

    1 trial

  19. Trelagliptin

    Takeda

    Type 2 Diabetes Mellitus

    approved small molecule completed

    2 trials

  20. Trelagliptin

    Takeda

    Type 2 Diabetes

    approved small molecule completed

    1 trial

  21. Vedolizumab

    Takeda

    Crohn Disease

    approved small molecule terminated

    4 trials

  22. Vedolizumab

    Takeda

    Moderately to Severely Active Crohn's Disease

    approved mab active

    1 trial

  23. Vedolizumab

    Takeda

    Crohn's Disease

    approved small molecule active

    6 trials

  24. Vedolizumab 300 mg

    Takeda

    Colitis, Ulcerative

    approved small molecule completed

    1 trial

  25. Vedolizumab IV

    Takeda

    Colitis, Ulcerative

    approved small molecule completed

    1 trial

  26. Vedolizumab Placebo

    Takeda

    Pouchitis

    approved small molecule completed

    1 trial

  27. Vedolizumab-3043

    Takeda

    Chron's Disease

    approved small molecule active

    1 trial

  28. Velaglucerase Alfa

    Takeda

    Gaucher Disease

    approved small molecule completed

    4 trials

  29. Vonoprazan

    Takeda

    Reflux Esophagitis

    approved small molecule completed

    1 trial

  30. Vonoprazan

    Takeda

    Erosive Esophagitis

    approved small molecule completed

    3 trials

  31. Vortioxetine

    Takeda

    Type2 Diabetes

    approved small molecule terminated

    1 trial

  32. Vortioxetine

    Takeda

    Depressive Disorder

    approved small molecule terminated

    1 trial

  33. Vortioxetine

    Takeda

    Healthy Volunteers

    approved small molecule completed

    1 trial

  34. Vortioxetine

    Takeda

    Schizophrenia

    approved small molecule active

    1 trial

  35. Vortioxetine

    Takeda

    Unipolar Major Depression

    approved small molecule terminated

    1 trial

  36. Vortioxetine 10 mg

    Takeda

    Age-related Cognitive Decline

    approved small molecule completed

    1 trial

  37. Vyvanse (lisdexamfetamine dimesylate)

    Takeda

    Attention Deficit Hyperactivity Disorder (ADHD)

    approved small molecule completed

    1 trial

  38. alogliptin+pioglitazone

    Takeda

    Diabetes Mellitus, Type 2

    approved small molecule terminated

    1 trial

  39. aspirin and/or clopidogrel

    Takeda

    Early Gastric Cancer

    approved small molecule active

    1 trial

  40. dexlansoprazole

    Takeda

    Laryngopharyngeal Reflux

    approved small molecule active

    1 trial

  41. lubiprostone

    Takeda

    Healthy

    approved small molecule completed

    1 trial

  42. lubiprostone

    Takeda

    Chronic Idiopathic Constipation

    approved small molecule completed

    3 trials

  43. lubiprostone (Amitiza)

    Takeda

    Colonoscopy

    approved small molecule completed

    1 trial

  44. midodrine hydrochloride (ProAmatine®)

    Takeda

    Hypotension, Orthostatic

    approved small molecule terminated

    1 trial

  45. pioglitazone

    Takeda

    Type 2 Diabetes

    approved small molecule completed

    1 trial

  46. pioglitazone

    Takeda

    Type 2 Diabetes Mellitus

    approved small molecule completed

    4 trials

  47. placebo

    Takeda

    Constipation

    approved small molecule completed

    1 trial

  48. prucalopride

    Takeda

    Chronic Constipation

    approved small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Takeda have?

1,179 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.